Mechanism of anaemia in rheumatoid arthritis: demonstration of raised interleukin 1 beta concentrations in anaemic patients and of interleukin 1 mediated suppression of normal erythropoiesis and proliferation of human erythroleukaemia (HEL) cells in vitro.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Annals of the Rheumatic Diseases

• Publication date

  1988-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/ard.47.12.972PMID 3264697PMCID PMC1003648
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumour necrosis factor--an overview.

  2009cited by this paper
• Interleukin 1 and the pathogenesis of inflammatory diseases.

  2009cited by this paper
• A lipophilic iron chelator induces an enhanced proliferation of human erythroleukaemia (HEL) cells.

  2009cited by this paper
• Interleukin 1 induces human marrow stromal cells in long-term culture to produce granulocyte colony-stimulating factor and macrophage colony-stimulating factor.

  1988cited by this paper
• SERUM IMMUNOREACTIVE INTERLEUKIN 1 IN RENAL TRANSPLANT RECIPIENTS: Association of Raised Levels With Graft Rejection Episodes1

  1988cited by this paper
• Interleukin 1 stimulates fibroblasts to synthesize granulocyte-macrophage and granulocyte colony-stimulating factors. Mechanism for the hematopoietic response to inflammation.

  1988cited by this paper
• Interleukin‐1

  1987cited by this paper
• Anaemia in juvenile chronic arthritis: serum inhibition of normal erythropoiesis in vitro.

  1987cited by this paper
• Hematopoietic growth factors.

  1987cited by this paper
• Effects of recombinant tumor necrosis factor on proliferation and differentiation of leukemic and normal hemopoietic cells in vitro. Relationship to cell surface receptor.

  1986cited by this paper
• Interleukin 1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2.

  1986cited by this paper
• Specific bioactivities of monocyte-derived interleukin 1 alpha and interleukin 1 beta are similar to each other on cultured murine thymocytes and on cultured human connective tissue cells.

  1986cited by this paper
• The cell surface receptors for interleukin-1 alpha and interleukin-1 beta are identical.

  1986cited by this paper
• Biological aspects of tumor necrosis factor.

  1986cited by this paper
• The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.

  1986cited by this paper
• Natural and recombinant human interleukin 1-beta is cytotoxic for human melanoma cells.

  1986cited by this paper
• Macrophage cytotoxicity: interleukin 1 as a mediator of tumor cytostasis.

  1986cited by this paper
• Multiple biological properties of recombinant human interleukin 1 (beta).

  1986cited by this paper
• The cell surface receptors for interleukin-1α and interleukin-1β are identical

  1986cited by this paper
• Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1

  1986cited by this paper
• Properties of a specific interleukin 1 (IL 1) receptor on human Epstein Barr virus-transformed B lymphocytes: identity of the receptor for IL 1-alpha and IL 1-beta.

  1986cited by this paper
• Human interleukin 1. Purification to homogeneity

  1985cited by this paper
• Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs

  1985cited by this paper
• Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon

  1985cited by this paper
• Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin 1 (IL-1) and purified human IL-1

  1985cited by this paper
• The four biochemically distinct species of human interleukin 1 all exhibit similar biologic activities.

  1985cited by this paper
• Interferons as macrophage-activating factors. III. Preferential effects of interferon-gamma on the interleukin 1 secretory potential of fresh or aged human monocytes.

  1985cited by this paper
• Increased plasma interleukin-1 activity in women after ovulation.

  1985cited by this paper
• Maple-syrup-urine disease.

  1984cited by this paper
• The mechanism of the anaemia in rheumatoid arthritis: effects of bone marrow adherent cells and of serum on in‐vitro erythropoiesis

  1984cited by this paper
• Cytokines and the chronic inflammation of rheumatic disease. II. The presence of interleukin-2 in synovial fluids.

  1984cited by this paper
• Comparative study of serum amyloid-related protein SAA, C-reactive protein, and beta 2-microglobulin as markers of renal allograft rejection.

  1984cited by this paper
• Interleukin-1.

  1984cited by this paper
• Silica-stimulated monocytes release fibroblast proliferation factors identical to interleukin 1. A potential role for interleukin 1 in the pathogenesis of silicosis.

  1984cited by this paper
• Demonstration of circulating leukocytic pyrogen/interleukin-1 during fever.

  1984cited by this paper
• Cytokines and the chronic inflammation of rheumatic disease. I. The presence of interleukin-1 in synovial fluids.

  1984cited by this paper
• Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells

  1984cited by this paper
• The effects of interleukin 1 on human B cell activation and proliferation.

  1983cited by this paper
• Inhibition of erythroid colony formation by autologous bone marrow adherent cells from patients with the anemia of chronic disease.

  1983cited by this paper
• Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever.

  1983cited by this paper
• An interleukin 1 like factor stimulates bone resorption in vitro

  1983cited by this paper
• Endogenous pyrogen activity in human plasma after exercise.

  1983cited by this paper
• The anemia of chronic disease.

  1983cited by this paper
• In vitro suppression of erythropoiesis by bone marrow adherent cells from some patients with fungal infection

  1982cited by this paper
• Interleukin l and T Cell Activation

  1982cited by this paper
• Interleukin 1 and T cell activation.

  1982cited by this paper
• Anaemia and chronic disease.

  1982cited by this paper
• Molecular basis of fever in humans.

  1982cited by this paper
• Accessory function of human tumor cell lines I Production of interleukin 1 by the human histiocytic lymphoma cell line U‐937

  1982cited by this paper
• Anaemia and chronic disease.

  1982cited by this paper
• HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression.

  1982cited by this paper
• Ability of human leukocytic pyrogen to enhance phytohemagglutinin induced murine thymocyte proliferation.

  1981cited by this paper
• A human soluble suppressor factor affecting lymphocyte responses in vitro.

  1980cited by this paper
• Cancer cell inhibition of erythropoiesis.

  1980cited by this paper
• Humoral suppression of erythropoiesis in systemic lupus erythematosus (SLE) and rheumatoid arthritis.

  1980cited by this paper
• Leukocytic endogenous mediator in Crohn's disease

  1978cited by this paper
• Enhancement of DNA synthesis and cAMP content of mouse thymocytes by mediator(s) derived from adherent cells.

  1976cited by this paper
• Partial replacement of serum by selenite, transferrin, albumin and lecithin in haemopoitec cell cultures

  1976cited by this paper
• Erythroid colony formation in cultures of mouse and human bone marrow: Analysis of the requirement for erythropoietin by gel filtration and affinity chromatography on agarose‐concanavalin A

  1974cited by this paper
• The anaemia of chronic disorders.

  1971cited by this paper
• Annotation: THE ANAEMIA OF CHRONIC DISORDERS

  1971cited by this paper
• Human bone marrow colony growth in agar‐gel

  1970cited by this paper

• Salidroside: A Potential Drug Candidate to Treat Rheumatoid Arthritis

  2025cites this paper
• Association between platelet-to-red cell distribution width ratio and all-cause mortality in critically ill patients with non-traumatic cerebral hemorrhage: a retrospective cohort study

  2024cites this paper
• More complications and higher transfusion rate in patients with rheumatoid arthritis than osteoarthritis undergoing total hip arthroplasty

  2023cites this paper
• Platelet and Red Blood Cell Volume Indices in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

  2022cites this paper
• A Prognostic Model Incorporating Red Cell Distribution Width to Platelet Ratio for Patients with Traumatic Brain Injury

  2021cites this paper
• The predictive value of RDW in AKI and mortality in patients with traumatic brain injury

  2020cites this paper
• Letter: high ferritin to haemoglobin ratio is related to early mortality in patients with alcoholic hepatitis

  2019cites this paper
• Anemia of cancer in a spontaneously breast cancer developing mouse model

  2019cites this paper
• Predictive biomarkers in rheumatoid arthritis

  2018cites this paper
• Predisposition of IL-1β (-511 C/T) polymorphism to renal and hematologic disorders in Indian SLE patients.

  2018cites this paper
• ESTIMATION OF HEMOGLOBIN AND SERUM FERRITIN CONCENTRATION FROM FEMALES WITH CHRONIC PERIODONTITIS BEFORE AND AFTER NON-SURGICAL PERIODONTAL THERAPY: AN INTERVENTIONAL STUDY

  2017cites this paper
• Non joint related complications of rheumatoid arthritis

  2017cites this paper
• Hematological Improvement of Patients with Active Rheumatoid Arthritis by β-D-Mannuronic Acid (M2000) as a Novel NSAID with Immunosuppressive Property.

  2017cites this paper
• Levels of Hemoglobin, ESR, Iron & TIBC in Rheumatoid Arthritis Patients Compared with Normal Individuals

  2016cites this paper
• Hepcidin‐dependent and hepcidin‐independent regulation of erythropoiesis in a mouse model of anemia of chronic inflammation

  2014cites this paper
• Interrelationship between chronic periodontitis and anemia: A 6-month follow-up study

  2014cites this paper
• DETERMINATION OF ERYTHROCYTE PARAMETERS IN CHRONIC PERIODONTITIS PATIENTS

  2014cites this paper
• Oxidative Stress and Role of Antioxidant in Osteoarthritis & Rheumatoid Arthritis: A Review Article

  2014cites this paper
• Red cell distribution width predicts mortality in infective endocarditis.

  2014cites this paper
• Extraskeletal Manifestations in Rheumatoid Arthritis - Clinical Cases

  2013cites this paper
• Anemia and Periodontitis: An Enigma?

  2013cites this paper
• Expression of (pro)renin receptor in human erythroid cell lines and its increased protein accumulation by interferon-γ.

  2012cites this paper
• The pathogenesis of anemia of chronic disorders

  2012influential citation
• Surgical Considerations of Rheumatoid Disease Involving the Craniocervical Junction and Atlantoaxial Vertebrae

  2012cites this paper
• The Anemia of Inflammation and Chronic Disease

  2012cites this paper
• Late stage erythroid precursor production is impaired in mice with chronic inflammation

  2012cites this paper
• IL1β down-regulation of sex hormone-binding globulin production by decreasing HNF-4α via MEK-1/2 and JNK MAPK pathways.

  2012cites this paper
• The pathogenesis of the anaemia of chronic disorders.

  2012cites this paper
• Evaluation of blood parameters in patients with chronic periodontitis for signs of anemia.

  2010cites this paper
• Role of interleukin-6 in the anemia of chronic disease.

  2009cites this paper
• Anémies par troubles du métabolisme du fer

  2009cites this paper
• Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state.

  2009cites this paper
• Prevalence of low hemoglobin levels and associations with other disease parameters in rheumatoid arthritis patients: evidence from the CORRONA registry.

  2009cites this paper
• Serum Pro-hepcidin Levels in Rheumatoid Arthritis and Systemic Lupus Erythematosus

  2008cites this paper
• Treatment strategies for amyloid A amyloidosis.

  2008cites this paper
• Pathophysiology of anemia in cancer

  2008cites this paper
• Treatment strategies for amyloid A amyloidosis

  2008cites this paper
• New insights into the regulation of iron homeostasis

  2006cites this paper
• Use of breath carbon monoxide measurements to assess erythrocyte survival in subjects with chronic diseases

  2006cites this paper
• Inflammatory cytokine inhibition of erythropoiesis in patients implanted with a mechanical circulatory assist device

  2005cites this paper
• Regulation of hepcidin transcription by interleukin-1 and interleukin-6.

  2005cites this paper
• Anaemia in rheumatoid arthritis: pathogenesis, diagnosis and treatment

  2004cites this paper
• Anaemia of chronic disease in AA amyloidosis is associated with allele 2 of the interleukin‐1β‐511 promoter gene and raised levels of interleukin‐1β and interleukin‐18

  2004cites this paper
• The role of cytokines in the pathogenesis of rheumatoid arthritis

  2004cites this paper
• Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis.

  2003cites this paper
• Use of recombinant erythropoietins for the treatment of anemia of chronic disease

  2003cites this paper
• [Anemia and erythropoietin in critically ill patients].

  2003cites this paper
• Serum hepcidin in clinical specimens

  2003cites this paper
• Pathophysiology of cancer-related anemia

  2002cites this paper
• Anaemia of critical illness-- implications for understanding and treating rHuEPO resistance.

  2002cites this paper
• Effects of Recombinant Human Interleukin-6 in Cancer Patients : A Phase 1-11 Study

  2002cites this paper
• Novel erythropoiesis stimulating protein (darbepoetin alfa) alleviates anemia associated with chronic inflammatory disease in a rodent model.

  2001cites this paper
• Anemia in critical illness.

  2001cites this paper
• Reply to “Is EDRF a specific marker for TSEs?”

  2001cites this paper
• Is EDRF a specific marker for TSEs?

  2001cites this paper
• Anemia of chronic disease is the more frequent type of anemia seen in patients with chronic idiopathic neutropenia of adults

  2001cites this paper
• The anaemia of infection.

  2000cites this paper
• Clinical decision-making in the investigation of anemias in hospitalized patients

  2000cites this paper
• Advances in the anemia of chronic disease.

  1999cites this paper
• Anémies inflammatoires et anémies des maladies chroniques

  1999cites this paper
• Role of cytokines in the pathogenesis of anemia of chronic disease in rheumatoid arthritis.

  1999cites this paper
• Current Status of Gene Therapy for Rheumatoid Arthritis

  1999cites this paper
• Pathogenesis of anaemia in the critically ill patient

  1998cites this paper
• High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome.

  1998cites this paper
• Iron, infections, and anemia of inflammation.

  1997cites this paper
• Pathogenesis and pathophysiology of anemia in HIV infection

  1997cites this paper
• Effect of Interleukin-1 α and Interleukin-1 β on Erythroid Progenitor Cell Growth in Serum Free Cultures: An In Vitro Study Relevant to the Pathogenesis of the Anemia of Chronic Disease.

  1997cites this paper
• Cytokine and Nitric Oxide Production in the Acute Phase of Bacterial Cell Wall-Induced Arthritis

  1997cites this paper
• Clinical erythrokinetics: a critical review.

  1997cites this paper
• The effect of clenbuterol and recombinant erythropoietin on tumor growth and the anemia caused by the Walker 256 carcinosarcoma.

  1997cites this paper
• Availability of iron and degree of inflammation modifies the response to recombinant human erythropoietin when treating anemia of chronic disease in patients with rheumatoid arthritis

  1997cites this paper
• Comparison between Intravenous and Subcutaneous Recombinant Human Erythropoietin (Epoetin Alfa) Administration in Presurgical Autologous Blood Donation in Anemic Rheumatoid Arthritis Patients Undergoing Major Orthopedic Surgery

  1997cites this paper
• Factors involved in the anaemia of chronic disorders in elderly patients.

  1997cites this paper
• Anaemia of chronic disease in rheumatoid arthritis: in vivo effects of tumour necrosis factor alpha blockade.

  1997cites this paper
• Use of Erythropoietin in Critically Ill Patients

  1997cites this paper
• Anemia of chronic disorders in systemic autoimmune diseases.

  1997cites this paper
• Cytokines and anaemia in human immunodeficiency virus infection.

  1997cites this paper
• Erythropoiesis and erythropoietin synthesis during aseptic acute inflammation

  1996cites this paper
• Epoetin in the Anaemia of Rheumatoid Arthritis

  1996cites this paper
• Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: a randomised placebo controlled double blind 52 weeks clinical trial.

  1996cites this paper
• Cellular mechanism of resistance to erythropoietin.

  1995cites this paper
• The acute phase response and the hematopoietic system: the role of cytokines.

  1995cites this paper
• Interaction of inflammatory cytokines and erythropoeitin in iron metabolism and erythropoiesis in anaemia of chronic disease

  1995cites this paper
• Serum erythropoietin and transferrin receptor levels in patients with rheumatoid arthritis.

  1995cites this paper
• Iron availability is transiently improved by intravenous iron medication in patients on chronic hemodialysis.

  1995cites this paper
• Pathogenesis of the anemia of chronic disease: A cytokine‐mediated anemia

  1995cites this paper
• Effects of recombinant human interleukin-6 in cancer patients: a phase I-II study.

  1994cites this paper
• Inhibition of murine erythroid colony formation in vitro by interferon gamma and correction by interferon receptor immunoadhesin.

  1994cites this paper
• Effect of exogenous erythropoietin on haem synthesis in anaemic patients with rheumatoid arthritis.

  1994cites this paper
• Serum transferrin receptors in rheumatoid arthritis.

  1994cites this paper
• Clinical application of recombinant erythropoietin in the anemia of chronic disease.

  1994cites this paper
• Circulating Erythropoietin Levels in Pathophysiological Conditions a

  1994cites this paper
• Use of recombinant human erythropoietin to assist autologous blood donation by anemic rheumatoid arthritis patients undergoing major orthopedic surgery

  1994cites this paper
• Prediction of response to erythropoietin treatment in chronic anemia of cancer.

  1994cites this paper
• Pathogenesis and Treatment of the Anemia of Chronic Disease

  1994cites this paper
• Cytokines and acute phase proteins in rheumatoid arthritis.

  1994cites this paper
• Microcytic anemia and changes in ferrokinetics as late after-effects of glucan administration in murine hepatitis virus-infected C57BL/10ScSnPh mice.

  1994cites this paper
• Is serum transferrin receptor useful for detecting iron-deficiency in anaemic patients with chronic inflammatory diseases?

  1994cites this paper
• Decreased affinity and number of transferrin receptors on erythroblasts in the anemia of rheumatoid arthritis

  1993cites this paper
• Cytokines and anti-cytokines.

  1993cites this paper